Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2020 Filed Nov 19, 2020 21:21 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
SaleCommon Stock | 1,571 | $3.40 | $5,341.40 |
DisclosureSEC source: 0001078782-20-000894 · primary_doc.xml · nonDerivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,378 Read SEC document |
| September 18, 2020 Filed Sep 18, 2020 21:21 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Exercise / conversionWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.47 | $0.00 |
DisclosureSEC source: 0001078782-20-000704 · primary_doc.xml · derivative · entry 3 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2020-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.underlying_shares: On September 18, 2020, the Reporting Person exercised a warrant to purchase 25,000 shares of Common Stock of the issuer for $2.47 per share. The warrant was set to expire pursuant to its terms on September 18, 2020. Read SEC document |
| September 18, 2020 Filed Sep 18, 2020 21:21 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Exercise / conversionCommon Stock | 25,000 | $2.47 | $61,750.00 |
DisclosureSEC source: 0001078782-20-000704 · primary_doc.xml · nonDerivative · entry 2 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2020 Filed Sep 18, 2020 21:21 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
SaleCommon Stock | 19,500 | $3.23 | $62,985.00 |
DisclosureSEC source: 0001078782-20-000704 · primary_doc.xml · nonDerivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,949 Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 14:55 UTC |
Faulkes Martin CharlesDirector
|
SaleCommon Stock | 65,000 | $3.21 | $208,650.00 |
DisclosureSEC source: 0001078782-20-000687 · primary_doc.xml · nonDerivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,943 F1 · kind: The shares of Common Stock were sold by the reporting person in a private transaction to Lagoda Investment Management, L.P., an existing stockholder of the Issuer. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:04 UTC |
Michel GaetanManager-Belgian Volition SPRL
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000658 · primary_doc.xml · derivative · entry 6 Gaetan Michel · CIK 0001709503 · Manager-Belgian Volition SPRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:04 UTC |
Michel GaetanManager-Belgian Volition SPRL
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000658 · primary_doc.xml · derivative · entry 5 Gaetan Michel · CIK 0001709503 · Manager-Belgian Volition SPRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:04 UTC |
Michel GaetanManager-Belgian Volition SPRL
|
Tax withholdingCommon Stock | 2,143 | $3.50 | $7,500.50 |
DisclosureSEC source: 0001078782-20-000658 · primary_doc.xml · nonDerivative · entry 4 Gaetan Michel · CIK 0001709503 · Manager-Belgian Volition SPRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise by the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:04 UTC |
Michel GaetanManager-Belgian Volition SPRL
|
Exercise / conversionCommon Stock | 2,500 | $3.00 | $7,500.00 |
DisclosureSEC source: 0001078782-20-000658 · primary_doc.xml · nonDerivative · entry 3 Gaetan Michel · CIK 0001709503 · Manager-Belgian Volition SPRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:04 UTC |
Michel GaetanManager-Belgian Volition SPRL
|
Tax withholdingCommon Stock | 1,786 | $3.50 | $6,251.00 |
DisclosureSEC source: 0001078782-20-000658 · primary_doc.xml · nonDerivative · entry 2 Gaetan Michel · CIK 0001709503 · Manager-Belgian Volition SPRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise by the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 17:04 UTC |
Michel GaetanManager-Belgian Volition SPRL
|
Exercise / conversionCommon Stock | 2,500 | $2.50 | $6,250.00 |
DisclosureSEC source: 0001078782-20-000658 · primary_doc.xml · nonDerivative · entry 1 Gaetan Michel · CIK 0001709503 · Manager-Belgian Volition SPRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 14:47 UTC |
Innes Guy ArchibaldDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000635 · primary_doc.xml · derivative · entry 5 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 14:47 UTC |
Innes Guy ArchibaldDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000635 · primary_doc.xml · derivative · entry 4 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 14:47 UTC |
Innes Guy ArchibaldDirector
|
Exercise / conversionCommon Stock | 15,000 | $3.00 | $45,000.00 |
DisclosureSEC source: 0001078782-20-000635 · primary_doc.xml · nonDerivative · entry 2 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 14:47 UTC |
Innes Guy ArchibaldDirector
|
Exercise / conversionCommon Stock | 15,000 | $2.50 | $37,500.00 |
DisclosureSEC source: 0001078782-20-000635 · primary_doc.xml · nonDerivative · entry 1 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,369,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000610 · primary_doc.xml · derivative · entry 8 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000610 · primary_doc.xml · derivative · entry 7 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Tax withholdingCommon Stock | 60,080 | $3.50 | $210,280.00 |
DisclosureSEC source: 0001078782-20-000610 · primary_doc.xml · nonDerivative · entry 4 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,928 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Exercise / conversionCommon Stock | 65,000 | $3.00 | $195,000.00 |
DisclosureSEC source: 0001078782-20-000610 · primary_doc.xml · nonDerivative · entry 3 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Tax withholdingCommon Stock | 55,158 | $3.50 | $193,053.00 |
DisclosureSEC source: 0001078782-20-000610 · primary_doc.xml · nonDerivative · entry 2 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,008 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Exercise / conversionCommon Stock | 65,000 | $2.50 | $162,500.00 |
DisclosureSEC source: 0001078782-20-000610 · primary_doc.xml · nonDerivative · entry 1 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:58 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000595 · primary_doc.xml · derivative · entry 6 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:58 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000595 · primary_doc.xml · derivative · entry 5 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:58 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Tax withholdingCommon Stock | 10,971 | $3.55 | $38,947.05 |
DisclosureSEC source: 0001078782-20-000595 · primary_doc.xml · nonDerivative · entry 4 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,449 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:58 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Exercise / conversionCommon Stock | 12,500 | $3.00 | $37,500.00 |
DisclosureSEC source: 0001078782-20-000595 · primary_doc.xml · nonDerivative · entry 3 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:58 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Tax withholdingCommon Stock | 9,580 | $3.55 | $34,009.00 |
DisclosureSEC source: 0001078782-20-000595 · primary_doc.xml · nonDerivative · entry 2 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,920 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 17:58 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Exercise / conversionCommon Stock | 12,500 | $2.50 | $31,250.00 |
DisclosureSEC source: 0001078782-20-000595 · primary_doc.xml · nonDerivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 14:32 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GiftOption (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000565 · primary_doc.xml · derivative · entry 6 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2021-07-23 F2 · kind: The option to purchase 55,000 shares of Common Stock of the Issuer was granted to Borlaug on July 23, 2015 under the Issuer's 2011 Plan. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 14:32 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GiftOption (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000565 · primary_doc.xml · derivative · entry 5 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2021-07-23 F2 · kind: The option to purchase 55,000 shares of Common Stock of the Issuer was granted to Borlaug on July 23, 2015 under the Issuer's 2011 Plan. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 14:32 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GiftOption (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000565 · primary_doc.xml · derivative · entry 4 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2020-08-18 F1 · kind: The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Borlaug Limited ("Borlaug"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the "2011 Plan"). Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 14:32 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GiftOption (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000565 · primary_doc.xml · derivative · entry 3 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2020-08-18 F1 · kind: The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Borlaug Limited ("Borlaug"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the "2011 Plan"). Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 14:32 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GiftOption (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000565 · primary_doc.xml · derivative · entry 2 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2020-08-18 F1 · kind: The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Borlaug Limited ("Borlaug"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the "2011 Plan"). Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 14:32 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GiftOption (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000565 · primary_doc.xml · derivative · entry 1 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2020-08-18 F1 · kind: The option to purchase an aggregate of 130,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Borlaug Limited ("Borlaug"), a consulting firm, on August 18, 2014 under the Issuer's 2011 Equity Incentive Plan (the "2011 Plan"). Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option. The option was then transferred by Borlaug to Dr. Micallef on July 27, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:41 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000560 · primary_doc.xml · derivative · entry 8 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:41 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000560 · primary_doc.xml · derivative · entry 7 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:41 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Tax withholdingCommon Stock | 43,627 | $3.95 | $172,326.65 |
DisclosureSEC source: 0001078782-20-000560 · primary_doc.xml · nonDerivative · entry 4 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,142,373 F1 · shares: Represents the aggregate number of shares of Common Stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:41 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | $3.00 | $150,000.00 |
DisclosureSEC source: 0001078782-20-000560 · primary_doc.xml · nonDerivative · entry 3 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,186,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:41 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Tax withholdingCommon Stock | 40,273 | $3.95 | $159,078.35 |
DisclosureSEC source: 0001078782-20-000560 · primary_doc.xml · nonDerivative · entry 2 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,136,000 F1 · shares: Represents the aggregate number of shares of Common Stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:41 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Exercise / conversionCommon Stock | 50,000 | $2.50 | $125,000.00 |
DisclosureSEC source: 0001078782-20-000560 · primary_doc.xml · nonDerivative · entry 1 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:32 UTC |
Faulkes Martin CharlesDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000559 · primary_doc.xml · derivative · entry 7 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:32 UTC |
Faulkes Martin CharlesDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000559 · primary_doc.xml · derivative · entry 6 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:32 UTC |
Faulkes Martin CharlesDirector
|
Tax withholdingCommon Stock | 26,177 | $3.95 | $103,399.15 |
DisclosureSEC source: 0001078782-20-000559 · primary_doc.xml · nonDerivative · entry 4 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570,943 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:32 UTC |
Faulkes Martin CharlesDirector
|
Exercise / conversionCommon Stock | 30,000 | $3.00 | $90,000.00 |
DisclosureSEC source: 0001078782-20-000559 · primary_doc.xml · nonDerivative · entry 3 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,597,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:32 UTC |
Faulkes Martin CharlesDirector
|
Tax withholdingCommon Stock | 24,164 | $3.95 | $95,447.80 |
DisclosureSEC source: 0001078782-20-000559 · primary_doc.xml · nonDerivative · entry 2 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,567,120 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:32 UTC |
Faulkes Martin CharlesDirector
|
Exercise / conversionCommon Stock | 30,000 | $2.50 | $75,000.00 |
DisclosureSEC source: 0001078782-20-000559 · primary_doc.xml · nonDerivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,591,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:23 UTC |
Rootsaert Rodney GerardSecretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000558 · primary_doc.xml · derivative · entry 7 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:23 UTC |
Rootsaert Rodney GerardSecretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-20-000558 · primary_doc.xml · derivative · entry 6 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:23 UTC |
Rootsaert Rodney GerardSecretary
|
Tax withholdingCommon Stock | 25,816 | $3.95 | $101,973.20 |
DisclosureSEC source: 0001078782-20-000558 · primary_doc.xml · nonDerivative · entry 4 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,398 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:23 UTC |
Rootsaert Rodney GerardSecretary
|
Exercise / conversionCommon Stock | 30,000 | $3.00 | $90,000.00 |
DisclosureSEC source: 0001078782-20-000558 · primary_doc.xml · nonDerivative · entry 3 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:23 UTC |
Rootsaert Rodney GerardSecretary
|
Tax withholdingCommon Stock | 23,614 | $3.95 | $93,275.30 |
DisclosureSEC source: 0001078782-20-000558 · primary_doc.xml · nonDerivative · entry 2 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,214 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.